WWH’s hedging of Merck-BMS data comp backfires Worldwide Healthcare Trust’s (WWH) apparent attempt to hedge its bet on the outcome of the three trials of anti-pd(L)-1 checkpoint inhibitors in first-line treatment of non-small cell lung cancer that were reported simultaneously yesterday appears to have backfired, after the stock market determined the data justified an asymmetric response. […]
Global Diversified Infrastructure IPO cancelled – On 1 March 2018, Global Diversified Infrastructure Plc (GDIV) announced the publication of a prospectus in relation to a proposed IPO that included a placing, offer for subscription and intermediaries offer and the admission of its shares to trading on the main market for listed securities of the London […]
Aberdeen Emerging Markets announces tender results – Aberdeen Emerging Markets (AEMC) has announced the results of its proposed Tender Offer on 19 February 2018 (click here). The tender is to be conducted at a price reflecting a discount of 3.5% to NAV, and so will be NAV accretive for remaining holders. AEMC’s Board says that […]
F&C Commercial Property underperforms in 2017 – the NAV total return of F&C Commercial Property (FCPT ) for the year was 8.8% and the share price total return was 3.9% for the year to 31 December 2017. The total return from the portfolio was 8.7%, whereas the MSCI Investment Property Databank (‘IPD’) Quarterly Benchmark Index returned 10.3% […]
US sanctions against Russia have minimal impact for JPMorgan Russian Securities – The board of JPMorgan Russian Securities (JRS) has put out a comment on the recent additional US sanctions against Russia. It is clear from the published statement that the latest sanctions imposed by the US on Russian companies has a limited impact on the portfolio of […]
Aberdeen Asian Smaller Companies gives details of CULS conversion – Aberdeen Asian Smaller Companies (AAS) has made announcements in January and February about converting its 3.5% convertible unsecured loan stock 2019 (2019 CULS). The company has announced further details in relation to the proposed restructuring of the 2019 CULS and the terms of a new class of convertible unsecured […]
Shire disposal leaves BB Healthcare stake in limbo Shire Pharmaceuticals’ announcement this morning of an agreement to sell its oncology business to Servier for $2.4bn in cash, leaves the stake in the company held by BB Healthcare Trust (BBH) – the only sector specialist investment trust to have significant exposure – in limbo. This is because […]
New Fund Manager for Schroder UK Growth – The Board of Schroder UK Growth Fund (SDU) announced that it has terminated Schroder Unit Trusts Limited as its AIFM and has appoint Baillie Gifford & Co Limited as the company’s new manager, company secretary and administrator. The board says that the Company’s long-term investment performance is considerably […]
Share split for Mercantile – The board of Mercantile (MRC) are proposing a ten-for-one share split to help deal with the share price being so high. It makes investing in smaller amounts hard 2017 was a good year for the share price. Over the year to 31st January 2018, the Company produced a return on net assets of […]
Worldwide Health offers a way to play AACR lung data reveal London-listed Worldwide Healthcare Trust (WWH) could be best way for trust investors to obtain exposure to what is likely to be the most important clinical data disclosure involving large cap pharmaceutical companies this year. This is set to occur next Monday (16 April) at the American Association […]
